![Open access](/images/ico/o.png)
![](/images/ico/ico5.png)
Author: Merin Noah M. Kelly Kevin R.
Publisher: MDPI
E-ISSN: 1424-8247|8|1|1-20
ISSN: 1424-8247
Source: Pharmaceuticals, Vol.8, Iss.1, 2014-12, pp. : 1-20
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/o.png)
![](/images/ico/ico5.png)
Novel Proteasome Inhibitors and Histone Deacetylase Inhibitors: Progress in Myeloma Therapeutics
Pharmaceuticals, Vol. 10, Iss. 2, 2017-04 ,pp. :
![](/images/ico/o.png)
![](/images/ico/ico5.png)
Tyrosine Kinase Inhibitors as Antiangiogenic Drugs in Multiple Myeloma
Pharmaceuticals, Vol. 3, Iss. 4, 2010-04 ,pp. :
![](/images/ico/o.png)
![](/images/ico/ico5.png)
![](/images/ico/o.png)
![](/images/ico/ico5.png)
The Role of Immunotherapy in Multiple Myeloma
By Kocoglu Mehmet Badros Ashraf
Pharmaceuticals, Vol. 9, Iss. 1, 2016-01 ,pp. :